NCT03093649

Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma

Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Patients With Nasopharyngeal Carcinoma Undergoing Intensity Modulated Radiation Therapy: A Randomised Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 320 (estimated)
• Sponsor: Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Although patient-reported adverse events have been promoted as an essential element in clinical trials and daily managements, their efficacy remained unknown. The purpose of this trial was to determine the effect of the patient-reported adverse events during the treatment on the improvements on quality of life.

Conditions

• Nasopharyngeal Neoplasms

Interventions

Type	Name	Description
OTHER	adverse events using patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire	The intervention was administrated through APP
OTHER	do not report adverse events through patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire	patients receive normal care and visit

Timeline

• Start date: 2017-07-01
• Primary completion: 2019-05-01
• Completion: 2019-05-01
• First posted: 2017-03-28
• Last updated: 2017-03-28

Locations

1 site across 1 country: China